Veterinary Medicines

Febrivac Dist liofilizat + rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań

Authorised
  • Canine distemper virus, strain Lederle D84/1, Live
Download as PDF

Product identification

Medicine name:
Febrivac Dist liofilizat + rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań
Active substance:
  • Canine distemper virus, strain Lederle D84/1, Live
Target species:
  • Ferret
  • Mink
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain Lederle D84/1, Live
    158489.00
    50% tissue culture infectious dose
    /
    1.00
    50% tissue culture infectious dose
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Ferret
      • All relevant tissues
        no withdrawal period
    • Mink
      • All relevant tissues
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI20CD01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • IDT Biologika GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • IDT Biologika GmbH
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 1264
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 15/11/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."